2-Tetrahydrofurylethylamine
| Clinical data | |
|---|---|
| Other names | TH-FEA; 2-(2-Tetrahydrofuryl)ethylamine; 2-Aminoethyltetrahydrofuran; Tetrahydrofurfurylmethylamine |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.252.264 |
| Chemical and physical data | |
| Formula | C6H13NO |
| Molar mass | 115.176 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
2-Tetrahydrofurylethylamine (TH-FEA or 2-(2-tetrahydrofuryl)ethylamine) is a drug related to the arylalkylamines. Analogues include 2-furylethylamine (FEA), 2-pyrrolylethylamine (NEA), β-phenethylamine, amphetamine, and thiopropamine, among others. A few derivatives of TH-FEA are known. The compound is pharmacologically active, producing a strong constricting effect on the uterus. TH-FEA was first described in the scientific literature by 1920.